Liu, Ziyu
Lu, Wenhui
Gao, Ling
Guo, Xiaojuan
Liu, Jie
Gao, Fan
Huo, Kang
Wang, Jin
Qu, Qiumin http://orcid.org/0000-0002-5634-6209
Funding for this research was provided by:
CSPC NBP PHARMACEUTICAL CO.
Article History
Received: 17 February 2022
Accepted: 1 November 2022
First Online: 16 November 2022
Declarations
:
: The trial has been approved by the Institutional Review Board/Ethics Committee in the First Affiliated Hospital of Xi’an Jiaotong University (approval number: XJTU1AF2020LSK-032).Written informed consent to participate will be obtained from all the participants.
: Written informed consent for publication will be obtained if necessary.
: The CSPC NBP PHARMACEUTICAL CO. funded the study and donated some of the study medication. The results of this study may help expand the scientific knowledge of its products, thus may causing financial competing interests in the future.